Aptorum Group: Aptorum is Hong Kong based, US listed company (Mcap $100m) focused on generating late stage clinical candidates by developing already approved drugs for new orphan indications, as well as infectious diseases.

Pipeline –
• SACT-1 for Neuroblastoma – ph2/3 trial planned for 2H’20
• SACT-COV19 – COVID-19 treatment - preclinical
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Asia
Listing
Public, USA
Market Cap
<100MM
Website:
Profiles:
Address:
17/F, Guangdong Investment Tower
148 Connaught Road
Hong Kong, Hong Kong Island 999077
Hong Kong

Top 10 Holders of Aptorum Group Limited Class A

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Citadel LP 0.19 12,753 0.02 13F 6/30/20
Geode Capital Management LLC 0.02 1,449 0.00 Funds 7/31/20
Deutsche Bank AG (13F Subfiler) 0.00 0 0.00 13F 6/30/20
UBS Group AG (13f Subfiler) 0.00 0 0.00 13F 6/30/20
Morgan Stanley Capital Services LLC 0.00 0 0.00 13F 6/30/20
Renaissance Technologies LLC 0.00 0 0.00 13F 6/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.